Literature DB >> 23477623

Comparison of the inhibitory effect against copper ion-induced oxidation in rat plasma after oral administration of salvianolic acid B and its decocted solutions.

Hyoung Jae Lee1, Jeong-Yong Cho, Jae-Hak Moon.   

Abstract

The effects of salvianolic acid B (Sal B) decoction on antioxidative activities were evaluated. The 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical-scavenging activity, Fe(2+)-chelating activity, reducing power, and total phenolic content of the Sal B-decocted solutions did not change significantly after decoction in an aqueous solution. However, the formation of cholesteryl ester hydroperoxide (CE-OOH) in rat blood plasma containing the Sal B-decocted solutions was more effectively inhibited than that of plasma containing the Sal B solution, regardless of the decoction time. In addition, the accumulation of CE-OOH in rat plasma after oral administration of the Sal B-decocted solutions was more effectively suppressed than when the Sal B solution was administered, considering the lag time. It is likely that the decoction was partly responsible for the increased antioxidant activity in blood plasma. Therefore, the Sal B-decocted solution may contribute more to antioxidant defense in blood than a Sal B solution that is not decocted.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23477623     DOI: 10.1089/jmf.2012.2456

Source DB:  PubMed          Journal:  J Med Food        ISSN: 1096-620X            Impact factor:   2.786


  2 in total

1.  Elucidating the influence of gold nanoparticles on the binding of salvianolic acid B and rosmarinic acid to bovine serum albumin.

Authors:  Xin Peng; Wei Qi; Renliang Huang; Rongxin Su; Zhimin He
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

2.  Salvianolic acid B protects hepatocytes from H2O2 injury by stabilizing the lysosomal membrane.

Authors:  Xiao-Feng Yan; Pei Zhao; Dong-Yan Ma; Yi-Lu Jiang; Jiao-Jiao Luo; Liu Liu; Xiao-Ling Wang
Journal:  World J Gastroenterol       Date:  2017-08-07       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.